Effectiveness and Duration of Effect of Open Treatment in Attention Deficit Hyperactivity Disorder (ADHD) Patients Treated With Lisdexamfetamine Dimesylate(Vyvanse)

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG

LDX Treatment

30 mg, 50mg, or 70 mg. Oral capsule, once a day, for 12 weeks.

Trial Locations (1)

NYU School of Medicine, New York